Chemoinformaics analysis of 6-METHYL-CYCLODEC-5-ENOL
| Molecular Weight | 168.28 | nRot | 0 |
| Heavy Atom Molecular Weight | 148.12 | nRig | 10 |
| Exact Molecular Weight | 168.151 | nRing | 1 |
| Solubility: LogS | -3.026 | nHRing | 0 |
| Solubility: LogP | 3.584 | No. of Aliphatic Rings | 1 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 1 |
| Atoms Count | 32 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 12 | No. of Aromatic Carbocycles | 0 |
| nHetero | 1 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 20 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 11 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 1 | No. of Arom Bond | 0 |
| nHA | 1 | APOL | 32.5079 |
| nHD | 1 | BPOL | 20.0641 |
| QED | 0.551 |
| Synth | 3.217 |
| Natural Product Likeliness | 1.579 |
| NR-PPAR-gamma | 0.462 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0.003 |
| Pgp-sub | 0.23 |
| HIA | 0.007 |
| CACO-2 | -4.458 |
| MDCK | 0.0000267 |
| BBB | 0.814 |
| PPB | 0.917392 |
| VDSS | 1.234 |
| FU | 0.0749325 |
| CYP1A2-inh | 0.635 |
| CYP1A2-sub | 0.437 |
| CYP2c19-inh | 0.218 |
| CYP2c19-sub | 0.232 |
| CYP2c9-inh | 0.126 |
| CYP2c9-sub | 0.845 |
| CYP2d6-inh | 0.013 |
| CYP2d6-sub | 0.238 |
| CYP3a4-inh | 0.033 |
| CYP3a4-sub | 0.113 |
| CL | 12.812 |
| T12 | 0.49 |
| hERG | 0.016 |
| Ames | 0.008 |
| ROA | 0.013 |
| SkinSen | 0.941 |
| Carcinogencity | 0.634 |
| EI | 0.985 |
| Respiratory | 0.097 |
| NR-Aromatase | 0.037 |
| Antiviral | No |
| Prediction | 0.812391 |